GENZYME CORP: ‘775 Patent Dispute with Impax Remains Ongoing
Genzyme Corporation remains in dispute with Impax Laboratories, Inc. over U.S. Patent No. 5,667,775, which expires in 2014.
The Company received notice in 2009, from Impax that it had submitted to…